Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Regdanvimab Authorized Experimental Antiviral Jan/18/2023 6 5
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 4
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Cobimetinib Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021 2 0
Bosutinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Ponatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Sunitinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021 10 0
Excel (.xslx) CSV (.csv)